Stay updated with breaking news from Intelligent Tissue Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL,...
/PRNewswire/ -- The "Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL,...
Share this article Share this article ResearchAndMarkets.com's offering. The global leukapheresis products market is projected to reach USD 91 million by 2026 from USD 61 million in 2021, at a CAGR of 8.4% during the forecast period. The leukopaks market is expected to reach USD 662 million by 2026, at a CAGR of 41.9%. Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes. The increasing incidence and prevalence of leukemia and the growing demand for leukopaks for research applications are some of the factors driving the growth of these markets. Howeve...
By Dr Morag McFarlane AS the unwavering commitment to vaccine development becomes the new norm, we find ourselves relying more heavily than ever before on volunteers and clinical trials. The news of effective vaccines signalled a light at the end of the tunnel that the world had been yearning for since the coronavirus pandemic struck. It immediately became the trending topic on social media, news channels and outlets around the globe. The narrative was peppered with praise for the hard-working teams of scientists behind the breakthrough – and rightly so. Their efforts will undoubtedly...